GenomeFrontier selects BioCina to help make cancer therapy products
GenomeFrontier Theraputics AU has partnered with BioCina for a project to develop products for gene therapy cancer treatments.
WA gov to kickstart medical start-ups
The West Australian government has provided $4.3 million in seed funding for health and medical start-ups to boost the sector’s manufacturing in the state. Nine companies will receive support from the 2022-23 Future Health Research and Innovation (FHRI) Fund Innovation Seed Fund, which will help them develop and commercialise their projects, as well as enhance…
Government grants EMVision funding for brain scanner
Medical device maker EMVision has been awarded $5 million in funding by the Department of Industry, Science and Resources to aid commercialisation of its portable brain scanner. EMVision was awarded the $5 million under the Modern Manufacturing Initiative grant award under the Medical products Manufacturing Translation steam to help establish commercial production of its 1st…
dorsaVi develops new spinal sensor tech with Medtronic
Australian medical technology firm dorsaVi has developed wearable sensors to monitor people with spinal conditions. Working with global medtech giant Medtronic, the two companies have collaborated to make the first beta version of a new sensor for the assessment of the quality of movement in patients suffering from a range of spinal conditions. The sensors…
Medical marijuana maker R&D tax break as CEO steps down
Australian medical marijuana manufacturer Cann Group has received a $4.3 million tax incentive rebate for its R&D into medicinal cannabis. The rebate relates to its in-house research activities as well as activities conducted through its work with key partners. This work includes recent clinical trials of its low-dose CBD capsules’ efficacy in reducing short-term sleep…
Cochlear trialling next-generation, fully implantable hearing aids
The Australian Financial Review reports that Cochlear is trialling a completely internal version of its hearing devices on one patient, and is looking to do so in 10 or so patients over the next two years.